Independent analysis puts a QYB liraglutide lot at 96.9%, against 96.0% on the certificate
The result is unremarkable. What the report omits is not.
March 2025 — Vol. 2, No. 3
Page 3 of 4 of this archive, newest first.
Also filed — page 3
the rolling newsroom, March 2025CPC declines, for the 7th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Halvard & Pike Apothecary of Portland, Maine enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
A supplier suspends shipping to Switzerland after 19 consecutive customs detentions
The route did not close because of a rule about peptides.
REWIND misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Independent analysis puts a Homopeptide mazdutide lot at 99.2%, against 98.5% on the certificate
The report states the gradient, the wavelength and the integration threshold, which is more than most.
What the new the United Arab Emirates guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
What changed at JEEP in March, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
PeptideMeter result on a Xi'an dulaglutide lot lands 2.6 points below the supplier’s figure
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
SSA declines, for the 13th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What the new South Africa guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
Calder Vale Peptides of Skipton closes after 9 years
A proper account of an operation that existed, and of what closing it cost.
From the floor in Changsha: 6 posters, one theme
Reported from the sessions, and from the two hours afterwards.
What a 42% rise in coupling-reagent prices does to a 20 mg vial
Follow the resin, not the catalogue.
A shortage listing ends. 9 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
The online reseller trading as Adamant Research Supply enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
France health authority warns on falsified exenatide pens
Reported from the analysis, not from a warning notice.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
From the floor in Suzhou: 17 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
A shortage listing ends. 3 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
What changed at SWB in March, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
VendorInvestigate result on a Hangzhou dulaglutide lot lands 2.2 points below the supplier’s figure
The result is unremarkable. What the report omits is not.
Calder Vale Peptides of Skipton closes after 6 years
A proper account of an operation that existed, and of what closing it cost.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
TRIUMPH-1 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Saudi Arabia health authority warns on falsified dulaglutide pens
Reported from the analysis, not from a warning notice.
What an 8% rise in coupling-reagent prices does to a 30 mg vial
Follow the resin, not the catalogue.
STEP 2 extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.